NYSE MKT LLC · OGEN
+1.17% · +$0.0064 · Vol 14.0K
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
Oragenics Inc

Oragenics Inc

Biotechnology
$0.5499
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
OGEN
Oragenics Inc
Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is OGEN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading OGEN catalysts
About Oragenics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2003
Employees
3
Country
US

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.5500
Day high
$0.5510
Day low
$0.5377
Previous close
$0.5435
52W high
$1.42
-61.27% from high
52W low
$0.4902
6% of range
Market cap
$2.5M
EPS
$-5.6900
Beta
0.93
Shares out
4.5M
Volume
14K
0.51× rel vol
Avg volume
27.3K
VWAP
$0.5473
Price history computed in-house
1W
+9.98%
1M
-4.60%
3M
-7.89%
1Y
-52.59%
YTD
-29.79%
SMA 50 $0.5693 · below
SMA 200 $0.7565 · below
52W position 6%

OGEN overview

Veridion Score
59
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around OGEN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading OGEN Form 4 filings
Public disclosures

Congress activity in OGEN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for OGEN in the cached public ledger.

Federal contracts

OGEN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OGEN in this window.
Lobbying spend

OGEN lobbying filings, year to date.

Registered lobbying filings matched to Oragenics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for OGEN in this window.
Loading news for OGEN
Analyst ratings
Sovereign unlock shows live analyst consensus for OGEN.
Options
Sovereign unlock shows live options positioning for OGEN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.